Medical devices with human blood or plasma derivatives

This procedure establishes safety and quality requirements for medical devices that contain stable substances derived from human blood or plasma. It aims to ensure that these products are safe for patients and meet strict health standards before entering the market.

This affects medical device manufacturers and healthcare providers. It introduces stricter rules on labeling and consumer information to ensure transparency regarding the origin and safety of blood-derived components.